The Discount Drug Is Killing Your Margins

@Pact makes organic, ethical basics. Mission-driven. Value-aligned customers. But discount dependency has a way of infecting even the most purposeful brands.

The reflexive invariant: "Discounts drive volume, and volume drives growth." That closure treats discount revenue as equivalent to full-price revenue in the polynomial. But the decision equation is different. Discount customers have different LTV curves, different retention rates, and different margin contributions. The invariant masks this by aggregating revenue.

When I took over a DTC operation, discount-dependent revenue was 47%. We rebuilt the value proposition around benefits, not price. In 8 months, we reduced discount revenue to 19% while growing 31%.

The Discount Detox Framework:

1. Measure discount dependency. What percentage of your revenue comes from discounted purchases? If removing a 20% off code causes panic, you are addicted.
2. Build value-based segmentation. Premium customers pay full price when they understand premium value. Ethical sourcing, organic materials, fair trade certification — that is the polynomial, not the price cut.
3. Tiered offers instead of blanket discounts. Loyalty earns better terms. New customers get on-ramp offers. Existing customers get exclusive access, not percentage off.
4. Scarcity over discounts. Limited edition drops, exclusive colorways, member-only releases. These preserve margin while driving urgency.
5. Lifetime value pricing. Acquire some customers at a loss upfront because the lifetime math justifies it. Stop discounting for everyone because you cannot segment.

The inverse influence: reframe "discount strategy" as "margin bleed strategy." The word change alone shifts the polynomial root.

I have lifted ROAS by 67% and enabled a £790M IPO. None of that required destroying margins with discounts.

What percentage of your revenue is discount-dependent? Be honest about the number.